应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRK 默沙东
交易中 06-16 14:57:46 EDT
114.96
+0.06
+0.05%
最高
115.89
最低
113.57
成交量
556.39万
今开
115.88
昨收
114.90
日振幅
2.02%
总市值
2,853亿
流通市值
2,853亿
总股本
24.82亿
成交额
6.39亿
换手率
0.22%
流通股本
24.82亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
默沙东:在中国获批用于婴幼儿下呼吸道感染治疗
美股速递 · 06-15 15:38
默沙东:在中国获批用于婴幼儿下呼吸道感染治疗
默沙东(MRK)旗下默克动物保健收购动物农业科技创新企业TARGAN
金吾财讯 · 06-11
默沙东(MRK)旗下默克动物保健收购动物农业科技创新企业TARGAN
默沙东高管表示:我们关注更广泛的肥胖领域,但更聚焦于其并发症而非单纯肥胖
美股速递 · 06-09
默沙东高管表示:我们关注更广泛的肥胖领域,但更聚焦于其并发症而非单纯肥胖
默沙东高管表示:“国家授予恩利西肽的优先审评券正稳步推进”
美股速递 · 06-09
默沙东高管表示:“国家授予恩利西肽的优先审评券正稳步推进”
默沙东CEO于高盛医疗健康大会表示:公司将聚焦10亿至150亿美元并购“甜蜜点”
美股速递 · 06-09
默沙东CEO于高盛医疗健康大会表示:公司将聚焦10亿至150亿美元并购“甜蜜点”
默沙东(MRK.US)与吉利德科学(GILD.US)联合HIV药物三期临床试验达主要终点
智通财经 · 06-09
默沙东(MRK.US)与吉利德科学(GILD.US)联合HIV药物三期临床试验达主要终点
吉利德科学:Islatravir/Lenacapavir HIV治疗方案在两项试验中均达到第48周主要疗效终点
美股速递 · 06-09
吉利德科学:Islatravir/Lenacapavir HIV治疗方案在两项试验中均达到第48周主要疗效终点
吉利德科学:Trodelvy与Keytruda联用的安全性特征与各药物已知安全性一致
美股速递 · 06-09
吉利德科学:Trodelvy与Keytruda联用的安全性特征与各药物已知安全性一致
吉利德科学宣布终止Trodelvy联合Keytruda的III期Keynote-D46/Evoke-03研究
美股速递 · 06-09
吉利德科学宣布终止Trodelvy联合Keytruda的III期Keynote-D46/Evoke-03研究
默沙东欣瑞来重磅上市,填补针对肺动脉高压根源治疗空白
上观新闻 · 06-08
默沙东欣瑞来重磅上市,填补针对肺动脉高压根源治疗空白
异动解读|默沙东盘中上涨3.44%,制药板块整体反弹叠加HIV新药获中国优先审评
行情直击 · 06-04
异动解读|默沙东盘中上涨3.44%,制药板块整体反弹叠加HIV新药获中国优先审评
Apotex推出西格列汀片及西格列汀盐酸二甲双胍片,符合180天共享独占期资格
美股速递 · 06-03
Apotex推出西格列汀片及西格列汀盐酸二甲双胍片,符合180天共享独占期资格
百年德企重仓深圳,不止于制造
21世纪经济报道 · 06-03
百年德企重仓深圳,不止于制造
异动解读|默沙东盘中下跌3.01%,报115.17美元
行情直击 · 06-01
异动解读|默沙东盘中下跌3.01%,报115.17美元
Adcendo Aps:双方公司保留各自化合物全部商业权利,涵盖单药及联合疗法
美股速递 · 05-26
Adcendo Aps:双方公司保留各自化合物全部商业权利,涵盖单药及联合疗法
Adcendo Aps与默沙东达成临床合作与供应协议,共同评估Adce-T02与Keytruda联合疗法
美股速递 · 05-26
Adcendo Aps与默沙东达成临床合作与供应协议,共同评估Adce-T02与Keytruda联合疗法
Adcendo Aps达成协议:公司将资助1B期临床试验,默沙东将提供帕博利珠单抗
美股速递 · 05-26
Adcendo Aps达成协议:公司将资助1B期临床试验,默沙东将提供帕博利珠单抗
默沙东K药联合Padcev获欧盟CHMP积极意见,用于治疗顺铂不耐受肌层浸润性膀胱癌
环球市场播报 · 05-22
默沙东K药联合Padcev获欧盟CHMP积极意见,用于治疗顺铂不耐受肌层浸润性膀胱癌
默沙东股价因癌症数据上涨,为何这家制药商不会仅依赖一款“王牌药物”?
老虎资讯综合 · 05-22
默沙东股价因癌症数据上涨,为何这家制药商不会仅依赖一款“王牌药物”?
默沙东(MRK)与科伦联合研发取得突破 肺癌新药临床效果亮眼
金吾财讯 · 05-22
默沙东(MRK)与科伦联合研发取得突破 肺癌新药临床效果亮眼
加载更多
公司概况
公司名称:
默沙东
所属市场:
NYSE
上市日期:
--
主营业务:
默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。
发行价格:
--
{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":114.96,"timestamp":1781636266397,"preClose":114.9,"halted":0,"volume":5563865,"delay":0,"changeRate":0.0005221932114881468,"floatShares":2482022536,"shares":2482022536,"eps":3.575809,"marketStatus":"交易中","change":0.06,"latestTime":"06-16 14:57:46 EDT","open":115.88,"high":115.89,"low":113.57,"amount":638896253.3073751,"amplitude":0.020191,"askPrice":114.97,"askSize":80,"bidPrice":114.96,"bidSize":242,"shortable":3,"etf":0,"ttmEps":3.575809,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781640000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-745790400000,"exchange":"NYSE","adjPreClose":114.9,"dividendRate":0.028532,"preHourTrading":{"tag":"盘前","latestPrice":115.5,"preClose":114.9,"latestTime":"09:29 EDT","volume":4391,"amount":505970.31945,"timestamp":1781616586292,"change":0.6,"changeRate":0.005222,"amplitude":0.013218},"postHourTrading":{"tag":"盘后","latestPrice":115.16,"preClose":114.9,"latestTime":"19:59 EDT","volume":1587342,"amount":182389070.05266,"timestamp":1781567976218,"change":0.26,"changeRate":0.002263,"amplitude":0.004003},"volumeRatio":0.55617,"impliedVol":0.2964,"impliedVolPercentile":0.2948},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"1195877790","title":"默沙东:在中国获批用于婴幼儿下呼吸道感染治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1195877790","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195877790?lang=zh_cn&edition=full","pubTime":"2026-06-15 15:38","pubTimestamp":1781509132,"startTime":"0","endTime":"0","summary":"默沙东公司宣布,其用于治疗婴幼儿下呼吸道感染的药物已在中国获得监管批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU1929549753.HKD","IE00BLSP4239.USD","LU2112291526.USD","SG9999014559.SGD","LU0070302665.USD","LU1941712264.USD","LU2491050071.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2461242641.AUD","LU2106854487.HKD","IE00BBT3K403.USD","LU0320765646.SGD","LU0859254822.USD","LU0868494617.USD","LU1934455863.HKD","LU0234572021.USD","IE00B2B36J28.USD","LU0965509010.AUD","LU0861579265.USD","LU0942090050.USD","LU2360032135.SGD","LU0965508806.USD","LU1291159041.SGD","LU0106261372.USD","LU2433249047.HKD","LU1989772923.USD","LU1162221912.USD","IE00B1BXHZ80.USD","LU1974910355.USD","LU0211331839.USD","LU1093756168.USD","IE00BLSP4452.SGD","LU1989771016.USD","LU1917777945.USD","LU2468319806.SGD","LU0868494708.USD","LU2125909593.SGD","LU2361044949.HKD","LU1116320737.USD","LU0058720904.USD","LU0238689110.USD","LU1093756325.SGD","LU0320765489.SGD","LU1066053197.SGD","SG9999015341.SGD","LU2357627491.SGD","LU2125154935.USD","IE00BN8TJ469.HKD","LU2023250504.SGD","LU0203345920.USD","LU2491049909.HKD","IE000M9KFDE8.USD","LU0965509283.SGD","LU0965509101.SGD","LU0980610538.SGD","BK4534","SG9999014567.USD","LU1430594728.SGD","LU0265550359.USD","LU2361044865.SGD","LU2491050154.USD","LU1066051225.USD","BK4007","LU0098860793.USD","BK4516","LU0648001328.SGD","LU1037948897.HKD","IE00BJT1NW94.SGD","SG9999015358.SGD","LU2023250843.SGD","LU0122379950.USD","LU1923622614.USD","LU0266013472.USD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1941712348.USD","LU0130517989.USD","LU0432979614.USD","LU2125154778.USD","SG9999002232.USD","LU2125909247.SGD","LU2361045086.USD","IE0002141913.USD","LU1037948541.HKD","LU0130102774.USD","LU1201861249.SGD","LU1983299246.USD","BK4588","MRK","LU2324357040.USD","LU1035773651.USD","SGXZ57979304.SGD","BK4559","LU0477156953.USD","LU1066051498.USD","LU0289739699.SGD","LU1585245621.USD","LU0203347892.USD","SG9999013999.USD","IE00B4R5TH58.HKD","LU0985320562.USD","LU1934455277.USD","LU0208291251.USD","LU1989772840.SGD","IE00BJJMRZ35.SGD","LU0265550946.USD","LU1061106388.HKD","LU2089984988.USD","SG9999001176.USD","SG9999002224.SGD","LU1934455194.USD","SG9999001176.SGD","SG9999014575.USD","BK4585","LU1066051811.HKD","LU1699723380.USD","LU1571399168.USD","LU1069347547.HKD","LU1057294990.SGD","SG9999014542.SGD","BK4533","SG9999001440.SGD","BK4550","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289826","title":"默沙东(MRK)旗下默克动物保健收购动物农业科技创新企业TARGAN","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289826","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642289826?lang=zh_cn&edition=full","pubTime":"2026-06-11 19:03","pubTimestamp":1781175805,"startTime":"0","endTime":"0","summary":"作为TARGAN自2017年以来的核心投资者及最大股东之一,默克动物保健表示,此举旨在加速其在全球家禽生物制药及智能化设备领域的战略布局。行业分析人士认为, 默克动物保健此次从“战略股东”身份向前一步完成全资收购,不仅获得了TARGAN先进的研发能力,更实现了“动保疫苗”与“智能接种/分拣设备”的深度产业闭环。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301433","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250843.SGD","IE000M9KFDE8.USD","LU1974910355.USD","LU2125154935.USD","LU2433249047.HKD","LU1699723380.USD","LU0208291251.USD","LU0980610538.SGD","IE00B4R5TH58.HKD","BK4007","LU0122379950.USD","LU1037948541.HKD","LU1989772923.USD","LU2089984988.USD","SGXZ57979304.SGD","LU2361044865.SGD","BK4534","IE00BSNM7G36.USD","SG9999013999.USD","LU2112291526.USD","SG9999002224.SGD","LU0265550946.USD","LU0648001328.SGD","LU1037948897.HKD","LU2468319806.SGD","LU1066051811.HKD","LU0868494617.USD","IE00B2B36J28.USD","LU1585245621.USD","LU1061106388.HKD","LU0203345920.USD","LU1066053197.SGD","LU0098860793.USD","LU1023059063.AUD","LU0289739699.SGD","BK4585","LU0058720904.USD","LU0985320562.USD","SG9999014575.USD","LU1934455863.HKD","LU2360032135.SGD","BK4559","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1934455194.USD","SG9999014542.SGD","SG9999014567.USD","SG9999001176.SGD","LU1571399168.USD","IE00BBT3K403.USD","LU1066051225.USD","LU1983299246.USD","LU0320765489.SGD","LU0942090050.USD","LU1941712264.USD","LU2491049909.HKD","IE00BLSP4239.USD","LU2357627491.SGD","LU0211331839.USD","IE0002141913.USD","LU2324357040.USD","LU2491050071.SGD","LU1917777945.USD","LU0106261372.USD","LU2023250504.SGD","SG9999001440.SGD","LU1057294990.SGD","LU0868494708.USD","LU0265550359.USD","BK4516","LU0861579265.USD","LU0859254822.USD","LU0965509101.SGD","LU1093756168.USD","LU0130102774.USD","BK4588","IE00BFTCPJ56.SGD","LU0130517989.USD","LU1116320901.HKD","LU0070302665.USD","LU2125909247.SGD","LU1116320737.USD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU1430594728.SGD","LU1941712348.USD","LU0203347892.USD","LU1035773651.USD","LU0965508806.USD","BK4550","LU1066051498.USD","LU1989772840.SGD","LU1923622614.USD","LU2125909593.SGD","LU2125154778.USD","LU2361044949.HKD","IE00BJT1NW94.SGD","SG9999001176.USD","LU0320765646.SGD","MRK","SG9999014559.SGD","IE00BN8TJ469.HKD","LU0006306889.USD","LU0266013472.USD","LU0965509010.AUD","BK4533","IE00BLSP4452.SGD","LU0965509283.SGD","LU1291159041.SGD","LU2491050154.USD","LU1162221912.USD","SG9999002232.USD","LU2461242641.AUD","LU1069347547.HKD","LU1201861249.SGD","LU1934455277.USD","LU1929549753.HKD","LU2361045086.USD","SG9999015341.SGD","LU0432979614.USD","LU0234572021.USD","IE0009355771.USD","LU1989771016.USD","LU0238689110.USD","LU0477156953.USD","SG9999015358.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103572899","title":"默沙东高管表示:我们关注更广泛的肥胖领域,但更聚焦于其并发症而非单纯肥胖","url":"https://stock-news.laohu8.com/highlight/detail?id=1103572899","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103572899?lang=zh_cn&edition=full","pubTime":"2026-06-09 23:49","pubTimestamp":1781020196,"startTime":"0","endTime":"0","summary":"默沙东的一位高管近日指出,公司对更广泛的肥胖领域抱有浓厚兴趣,但其关注重点并非肥胖本身,而是与之相关的各类并发症。这番表态揭示了该公司在相关治疗领域可能采取的战略方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0289739699.SGD","LU1162221912.USD","LU0965509283.SGD","LU2125909247.SGD","LU0238689110.USD","LU1989772923.USD","SG9999014559.SGD","MRK","IE0002141913.USD","LU1037948897.HKD","LU2491050071.SGD","LU1116320737.USD","IE00BJT1NW94.SGD","LU0106261372.USD","LU1037948541.HKD","LU2324357040.USD","LU0006306889.USD","LU0122379950.USD","LU0211331839.USD","LU0942090050.USD","SG9999013999.USD","LU0130517989.USD","SG9999015341.SGD","LU0965509101.SGD","SG9999002232.USD","LU1571399168.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU2361045086.USD","LU1934455863.HKD","LU2357627491.SGD","LU1116320901.HKD","LU0208291251.USD","LU0868494708.USD","LU1699723380.USD","SG9999001176.SGD","SG9999002224.SGD","LU0859254822.USD","LU1923622614.USD","SG9999001176.USD","SG9999015358.SGD","LU1989772840.SGD","IE000M9KFDE8.USD","LU1069347547.HKD","LU1023059063.AUD","LU2361044865.SGD","LU2125909593.SGD","LU1585245621.USD","BK4007","SLIM","BK4534","LU0965509010.AUD","LU0266013472.USD","LU2433249047.HKD","BK4550","LU1061106388.HKD","BK4533","LU0648001328.SGD","LU1917777945.USD","LU0234572021.USD","LU1989771016.USD","LU2461242641.AUD","LU2468319806.SGD","LU2491049909.HKD","LU0320765489.SGD","LU1941712264.USD","LU1941712348.USD","LU2361044949.HKD","SG9999014567.USD","IE00BBT3K403.USD","SG9999014542.SGD","LU0965508806.USD","LU1066051225.USD","LU2360032135.SGD","IE00BLSP4452.SGD","LU1066051811.HKD","IE00BLSP4239.USD","LU2023250504.SGD","LU0203347892.USD","IE00B1BXHZ80.USD","IE0009355771.USD","IE00BN8TJ469.HKD","LU1093756168.USD","LU0130102774.USD","IE00B2B36J28.USD","LU0861579265.USD","LU0203345920.USD","SG9999014575.USD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0980610538.SGD","LU0265550359.USD","LU0477156953.USD","LU1430594728.SGD","BK4585","LU0985320562.USD","IE00BSNM7G36.USD","BK4559","LU1934455194.USD","LU1974910355.USD","LU0098860793.USD","LU2023250843.SGD","LU1929549753.HKD","LU2112291526.USD","LU2125154935.USD","LU0265550946.USD","LU2491050154.USD","LU1291159041.SGD","LU1201861249.SGD","LU0868494617.USD","LU0070302665.USD","LU2106854487.HKD","BK4588","LU1093756325.SGD","LU2125154778.USD","LU1066051498.USD","LU0432979614.USD","BK4516","LU1035773651.USD","SG9999001440.SGD","LU1934455277.USD","LU0320765646.SGD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190170745","title":"默沙东高管表示:“国家授予恩利西肽的优先审评券正稳步推进”","url":"https://stock-news.laohu8.com/highlight/detail?id=1190170745","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190170745?lang=zh_cn&edition=full","pubTime":"2026-06-09 23:49","pubTimestamp":1781020146,"startTime":"0","endTime":"0","summary":"默沙东的一位高管近日表示,公司有充分迹象表明,为旗下药物恩利西肽(Enlicitide)所获颁的国家优先审评凭证,其相关进程正在积极向前推进。这一表态传递出该关键监管激励措施进展顺利的明确信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU1929549753.HKD","IE00BLSP4239.USD","LU2112291526.USD","SG9999014559.SGD","LU0070302665.USD","LU1941712264.USD","LU2491050071.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2461242641.AUD","LU2106854487.HKD","IE00BBT3K403.USD","LU0320765646.SGD","LU0859254822.USD","LU0868494617.USD","LU1934455863.HKD","LU0234572021.USD","IE00B2B36J28.USD","LU0965509010.AUD","LU0861579265.USD","LU0942090050.USD","LU2360032135.SGD","LU0965508806.USD","LU1291159041.SGD","LU0106261372.USD","LU2433249047.HKD","LU1989772923.USD","LU1162221912.USD","IE00B1BXHZ80.USD","LU1974910355.USD","LU0211331839.USD","LU1093756168.USD","IE00BLSP4452.SGD","LU1989771016.USD","LU1917777945.USD","LU2468319806.SGD","LU0868494708.USD","LU2125909593.SGD","LU2361044949.HKD","LU1116320737.USD","LU0058720904.USD","LU0238689110.USD","LU1093756325.SGD","LU0320765489.SGD","LU1066053197.SGD","SG9999015341.SGD","LU2357627491.SGD","LU2125154935.USD","IE00BN8TJ469.HKD","LU2023250504.SGD","LU0203345920.USD","LU2491049909.HKD","IE000M9KFDE8.USD","LU0965509283.SGD","LU0965509101.SGD","LU0980610538.SGD","BK4534","SG9999014567.USD","LU1430594728.SGD","LU0265550359.USD","LU2361044865.SGD","LU2491050154.USD","LU1066051225.USD","BK4007","LU0098860793.USD","BK4516","LU0648001328.SGD","LU1037948897.HKD","IE00BJT1NW94.SGD","SG9999015358.SGD","LU2023250843.SGD","LU0122379950.USD","LU1923622614.USD","LU0266013472.USD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1941712348.USD","LU0130517989.USD","LU0432979614.USD","LU2125154778.USD","SG9999002232.USD","LU2125909247.SGD","LU2361045086.USD","IE0002141913.USD","LU1037948541.HKD","LU0130102774.USD","LU1201861249.SGD","LU1983299246.USD","BK4588","MRK","LU2324357040.USD","LU1035773651.USD","SGXZ57979304.SGD","BK4559","LU0477156953.USD","LU1066051498.USD","LU0289739699.SGD","LU1585245621.USD","LU0203347892.USD","SG9999013999.USD","IE00B4R5TH58.HKD","LU0985320562.USD","LU1934455277.USD","LU0208291251.USD","LU1989772840.SGD","IE00BJJMRZ35.SGD","LU0265550946.USD","LU1061106388.HKD","LU2089984988.USD","SG9999001176.USD","SG9999002224.SGD","LU1934455194.USD","SG9999001176.SGD","SG9999014575.USD","BK4585","LU1066051811.HKD","LU1699723380.USD","LU1571399168.USD","LU1069347547.HKD","LU1057294990.SGD","SG9999014542.SGD","BK4533","SG9999001440.SGD","BK4550","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104876485","title":"默沙东CEO于高盛医疗健康大会表示:公司将聚焦10亿至150亿美元并购“甜蜜点”","url":"https://stock-news.laohu8.com/highlight/detail?id=1104876485","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104876485?lang=zh_cn&edition=full","pubTime":"2026-06-09 23:36","pubTimestamp":1781019409,"startTime":"0","endTime":"0","summary":"在高盛医疗健康大会上,默沙东首席执行官阐述了公司的未来并购战略,明确指出将把重点放在交易规模在10亿至150亿美元之间的“甜蜜点”上。这一战略定位旨在通过精准且规模适中的收购,有效补充和强化公司的产品管线,同时平衡风险与增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","IE0009355771.USD","LU1585245621.USD","BK4533","SG9999014542.SGD","LU1066053197.SGD","LU1066051811.HKD","IE00BLSP4452.SGD","SG9999014567.USD","IE00B4R5TH58.HKD","SG9999002224.SGD","LU0965509101.SGD","LU2023250843.SGD","LU2125154778.USD","LU0122379950.USD","LU0965508806.USD","LU0006306889.USD","SG9999015341.SGD","BK4007","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU0265550946.USD","LU2125154935.USD","LU2491050154.USD","LU0965509010.AUD","LU2491049909.HKD","LU0868494617.USD","SG9999014575.USD","LU0859254822.USD","BK4534","LU1929549753.HKD","LU2125909247.SGD","LU1116320901.HKD","IE00BBT3K403.USD","LU1917777945.USD","LU0211331839.USD","IE00BSNM7G36.USD","LU0238689110.USD","LU0320765489.SGD","LU2361045086.USD","IE00BN8TJ469.HKD","LU2125909593.SGD","LU0130517989.USD","LU1061106388.HKD","LU0942090050.USD","SGXZ57979304.SGD","LU1941712264.USD","LU0648001328.SGD","LU2106854487.HKD","BK4559","LU1093756168.USD","LU1066051225.USD","BK4550","LU1057294990.SGD","LU2112291526.USD","LU2324357040.USD","LU1069347547.HKD","LU2360032135.SGD","LU0098860793.USD","LU0477156953.USD","LU1066051498.USD","LU1699723380.USD","LU1923622614.USD","LU0965509283.SGD","LU2089984988.USD","SG9999002232.USD","LU1941712348.USD","LU0980610538.SGD","LU1934455277.USD","LU2357627491.SGD","LU0234572021.USD","LU1093756325.SGD","LU1983299246.USD","IE00BJT1NW94.SGD","LU2023250504.SGD","LU0432979614.USD","LU0861579265.USD","LU1989771016.USD","IE000M9KFDE8.USD","LU1934455194.USD","LU2361044865.SGD","LU1989772840.SGD","IE00BLSP4239.USD","SG9999014559.SGD","LU1037948541.HKD","LU0106261372.USD","BK4588","SG9999001176.SGD","LU0130102774.USD","LU1934455863.HKD","LU0868494708.USD","LU2468319806.SGD","BK4585","LU1430594728.SGD","SG9999015358.SGD","LU1989772923.USD","IE00B2B36J28.USD","LU0320765646.SGD","IE0002141913.USD","LU0208291251.USD","LU0070302665.USD","LU0265550359.USD","LU1291159041.SGD","LU1116320737.USD","LU1571399168.USD","LU0203347892.USD","LU2491050071.SGD","LU1037948897.HKD","LU0266013472.USD","SG9999001440.SGD","LU1023059063.AUD","SG9999001176.USD","MRK","LU0203345920.USD","SG9999013999.USD","LU2433249047.HKD","LU1162221912.USD","LU0289739699.SGD","LU1035773651.USD","LU1974910355.USD","LU0058720904.USD","LU0985320562.USD","BK4516","LU2461242641.AUD","LU2361044949.HKD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642545787","title":"默沙东(MRK.US)与吉利德科学(GILD.US)联合HIV药物三期临床试验达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2642545787","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642545787?lang=zh_cn&edition=full","pubTime":"2026-06-09 14:47","pubTimestamp":1780987633,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,默沙东和吉利德科学表示,含有默沙东药物伊斯拉曲韦和吉利德药物莱那卡帕韦的复方药片的两项 3 期试验的初步结果达到了主要终点。此外,研究发现 islatravir/lenacapavir不劣于必妥维和标准口服抗逆转录病毒疗法。此外,两家公司宣布,根据数据监测委员会的建议,他们将终止吉利德的 Trodelvy 与默沙东的Keytruda一线治疗转移性非小细胞肺癌的 3 期 KEYNOTE-D46/EVOKE-03 研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0009355771.USD","LU0648001328.SGD","IE00BBT3K403.USD","LU0942090050.USD","LU2125909593.SGD","SG9999001440.SGD","LU0106261372.USD","IE00BLSP4239.USD","LU0320765992.SGD","LU1934455277.USD","LU2361044865.SGD","BK4583","LU2125154778.USD","LU0130517989.USD","IE0002141913.USD","BK4534","LU2112291526.USD","BK4588","LU0432979614.USD","LU2023250843.SGD","LU0868494708.USD","LU1778281490.HKD","LU1934455863.HKD","LU1917777945.USD","IE00B7SZLL34.SGD","IE00BLSP4452.SGD","LU1571399168.USD","LU0058720904.USD","LU1674673428.USD","IE00B4R5TH58.HKD","LU2461242641.AUD","LU1699723380.USD","IE00B2B36J28.USD","SG9999015341.SGD","LU0203347892.USD","LU0211331839.USD","LU0265550359.USD","GILD","LU0266013472.USD","LU1061106388.HKD","LU0965509283.SGD","SG9999014567.USD","LU2491050154.USD","LU1929549753.HKD","BK4532","LU1291159041.SGD","LU1674673691.USD","LU1093756325.SGD","IE0002270589.USD","BK4007","IE00B1BXHZ80.USD","IE00B19Z3581.USD","LU2360032135.SGD","LU0208291251.USD","LU0965508806.USD","LU1941712264.USD","LU1066051225.USD","LU2433249047.HKD","LU0130102774.USD","LU1116320737.USD","SG9999015945.SGD","LU1989771016.USD","SG9999001176.USD","LU0070302665.USD","SG9999015358.SGD","SG9999014542.SGD","LU1941712348.USD","LU0234570918.USD","LU1934455194.USD","SG9999002224.SGD","LU0868494617.USD","IE000M9KFDE8.USD","LU0098860793.USD","MRK","LU1066051498.USD","LU0238689110.USD","LU0289739699.SGD","LU1923622614.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","SG9999015952.SGD","LU1430594728.SGD","LU1069347547.HKD","LU1023059063.AUD","LU0965509010.AUD","LU2324357040.USD","BK4550","LU0006306889.USD","LU1066051811.HKD","LU1983299246.USD","LU0965509101.SGD","LU0823416689.USD","LU0980610538.SGD","BK4559","LU0234572021.USD","SG9999013999.USD","LU1066053197.SGD","LU0114720955.EUR","BK4578","LU0122379950.USD","SG9999002232.USD","LU0861579265.USD","LU2491049909.HKD","LU1162221912.USD","SG9999014575.USD","SG9999015978.USD","BK4139","LU2125154935.USD","IE00BZ1G4Q59.USD","BK4566","SG9999015986.USD","IE00BFTCPJ56.SGD","LU2089984988.USD","LU0109394709.USD","LU2106854487.HKD","LU2357627491.SGD","LU2125909247.SGD","LU0859254822.USD","LU1989772923.USD","LU1839511570.USD","LU1989772840.SGD","IE00BN8TJ469.HKD","LU1057294990.SGD","LU1201861249.SGD","LU1585245621.USD","LU0203345920.USD","LU1037948897.HKD","LU1035773651.USD","BK4516","LU2491050071.SGD","LU0320765646.SGD","IE00B3T34201.USD","LU1093756168.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU1116320901.HKD","LU2361044949.HKD","LU0985320562.USD","SGXZ57979304.SGD","BK4533","IE00BJT1NW94.SGD","LU2023250504.SGD","SG9999001176.SGD","LU1974910355.USD","BK4585","LU0265550946.USD","LU0882574055.USD","LU1037948541.HKD","LU2087621335.USD","BK4568","LU2468319806.SGD","LU0477156953.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","SG9999014559.SGD","LU2361045086.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181239601","title":"吉利德科学:Islatravir/Lenacapavir HIV治疗方案在两项试验中均达到第48周主要疗效终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1181239601","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181239601?lang=zh_cn&edition=full","pubTime":"2026-06-09 04:37","pubTimestamp":1780951065,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布,其基于islatravir与lenacapavir的HIV联合治疗方案,在两项关键临床试验中,均成功达到了预设的第48周主要疗效终点。这一积极结果标志着该创新疗法在抑制病毒载量方面展现出显著效果,为HIV感染者提供了潜在的全新长效治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","SG9999015986.USD","LU1934455194.USD","LU2357627491.SGD","LU0882574055.USD","LU2125154935.USD","MRK","BK4534","LU0965508806.USD","LU1983299246.USD","LU0432979614.USD","LU1291159041.SGD","SG9999002224.SGD","LU0106261372.USD","LU1934455863.HKD","LU1037948541.HKD","BK4566","IE0009355771.USD","SG9999014559.SGD","LU1035773651.USD","IE00B2B36J28.USD","LU0203347892.USD","IE00B7SZLL34.SGD","LU0889565916.HKD","BK4550","BK4533","IE00B19Z3581.USD","BK4588","BK4559","LU0122379950.USD","LU0868494617.USD","LU0006306889.USD","LU1066051225.USD","LU1023059063.AUD","LU1934455277.USD","LU0265550946.USD","SG9999001440.SGD","LU0859254822.USD","GILD","LU0208291251.USD","IE00B1BXHZ80.USD","LU2491049909.HKD","LU2023250504.SGD","SG9999002232.USD","IE00BKVL7J92.USD","LU1116320737.USD","BK4585","LU2324357040.USD","LU1116320901.HKD","LU0070302665.USD","LU1674673428.USD","LU0238689110.USD","LU1093756168.USD","LU1923622614.USD","BK4568","LU2361044949.HKD","IE00BZ1G4Q59.USD","LU2491050154.USD","LU2125909247.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0965509283.SGD","LU1069347547.HKD","LU0234572021.USD","BK4532","LU0289739699.SGD","LU0965509010.AUD","LU2112291526.USD","LU1839511570.USD","LU1066053197.SGD","LU1066051811.HKD","LU0823416689.USD","LU0211331839.USD","IE0002270589.USD","LU1941712264.USD","LU0058720904.USD","LU1061106388.HKD","LU2461242641.AUD","LU2491050071.SGD","SG9999015341.SGD","BK4516","IE00BN8TJ469.HKD","LU1037948897.HKD","LU0130102774.USD","LU0861579265.USD","LU0942090050.USD","LU2087621335.USD","IE00B19Z3B42.SGD","LU0980610538.SGD","LU2468319806.SGD","LU1917777945.USD","SG9999014567.USD","LU0985320562.USD","LU1093756325.SGD","LU1989771016.USD","LU2360032135.SGD","IE0002141913.USD","LU0098860793.USD","LU2433249047.HKD","BK4139","BK4583","SG9999015358.SGD","SG9999015945.SGD","IE00BJJMRZ35.SGD","LU1941712348.USD","LU1989772840.SGD","LU0109394709.USD","SG9999014575.USD","LU2125909593.SGD","LU1066051498.USD","LU2361045086.USD","IE00BBT3K403.USD","SG9999015952.SGD","LU1201861249.SGD","LU0320765646.SGD","LU0265550359.USD","LU0130517989.USD","LU2125154778.USD","BK4578","LU1162221912.USD","LU1929549753.HKD","SG9999014542.SGD","LU0234570918.USD","IE000M9KFDE8.USD","LU0266013472.USD","LU1778281490.HKD","LU0868494708.USD","SG9999001176.SGD","IE00B3T34201.USD","LU0648001328.SGD","SG9999001176.USD","LU1674673691.USD","LU1057294990.SGD","LU0477156953.USD","LU0965509101.SGD","LU2023250843.SGD","LU2361044865.SGD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","IE00BLSP4239.USD","LU1430594728.SGD","LU0114720955.EUR","LU2106854487.HKD","IE00BLSP4452.SGD","LU1585245621.USD","SGXZ57979304.SGD","BK4007","SG9999015978.USD","LU0203345920.USD","LU1974910355.USD","LU0320765489.SGD","LU1699723380.USD","LU2089984988.USD","LU1989772923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164602486","title":"吉利德科学:Trodelvy与Keytruda联用的安全性特征与各药物已知安全性一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1164602486","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164602486?lang=zh_cn&edition=full","pubTime":"2026-06-09 04:32","pubTimestamp":1780950760,"startTime":"0","endTime":"0","summary":"吉利德科学公司公布的数据显示,其抗体偶联药物Trodelvy与默沙东公司的Keytruda联合使用的安全性特征,与两种药物各自已知的安全性情况保持一致。这一发现为评估该联合疗法的潜力提供了重要的安全性基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","IE0002141913.USD","LU1989771016.USD","BK4516","LU1934455863.HKD","LU2361044865.SGD","SG9999002232.USD","LU1983299246.USD","BK4550","LU0106261372.USD","LU0130517989.USD","LU0211331839.USD","SG9999001176.USD","BK4559","SG9999014575.USD","SGXZ57979304.SGD","LU0006306889.USD","LU0265550359.USD","IE00BBT3K403.USD","BK4568","LU1989772923.USD","BK4534","LU1699723380.USD","BK4588","LU1430594728.SGD","IE00BLSP4452.SGD","LU1057294990.SGD","SG9999015358.SGD","BK4566","LU0965508806.USD","LU0238689110.USD","LU1069347547.HKD","LU1974910355.USD","LU0965509283.SGD","LU0320765489.SGD","LU2357627491.SGD","LU1934455277.USD","IE00BSNM7G36.USD","SG9999015986.USD","LU0980610538.SGD","LU0477156953.USD","LU0889565916.HKD","LU0823416689.USD","BK4532","IE00B3T34201.USD","LU2324357040.USD","LU1035773651.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","IE00BJT1NW94.SGD","LU0942090050.USD","BK4578","LU2125154935.USD","SG9999013999.USD","LU0203347892.USD","LU0432979614.USD","LU0965509010.AUD","LU0234572021.USD","LU0122379950.USD","LU1934455194.USD","LU2089984988.USD","LU1989772840.SGD","LU2106854487.HKD","LU0965509101.SGD","LU0203345920.USD","LU2023250504.SGD","IE0002270589.USD","IE0009355771.USD","LU1037948897.HKD","LU0208291251.USD","LU1571399168.USD","LU2112291526.USD","LU0130102774.USD","LU1093756325.SGD","LU0868494617.USD","LU1291159041.SGD","LU2468319806.SGD","LU0114720955.EUR","IE00BKVL7J92.USD","LU1116320901.HKD","LU2125909247.SGD","LU0868494708.USD","SG9999015945.SGD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU0098860793.USD","BK4533","LU1923622614.USD","GILD","LU0985320562.USD","BK4583","LU1674673428.USD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","IE00BN8TJ469.HKD","LU1037948541.HKD","IE00B19Z3581.USD","LU0320765646.SGD","LU1585245621.USD","LU2433249047.HKD","LU1778281490.HKD","LU1066051225.USD","SG9999002224.SGD","LU1093756168.USD","LU0266013472.USD","LU1201861249.SGD","SG9999001176.SGD","LU1023059063.AUD","LU0648001328.SGD","LU1941712264.USD","SG9999014567.USD","SG9999014559.SGD","LU0289739699.SGD","LU2125154778.USD","IE00B2B36J28.USD","LU0859254822.USD","LU2461242641.AUD","BK4585","LU1066051498.USD","SG9999015341.SGD","LU1929549753.HKD","LU2361045086.USD","LU1674673691.USD","LU0861579265.USD","LU2491049909.HKD","IE000M9KFDE8.USD","LU1066053197.SGD","SG9999001440.SGD","LU2125909593.SGD","LU1839511570.USD","LU2023250843.SGD","BK4007","IE00BJJMRZ35.SGD","SG9999015952.SGD","MRK","IE00B7SZLL34.SGD","LU2491050154.USD","LU1162221912.USD","IE00B4R5TH58.HKD","SG9999015978.USD","SG9999014542.SGD","LU1116320737.USD","LU2361044949.HKD","LU0234570918.USD","LU0265550946.USD","LU0109394709.USD","LU1941712348.USD","LU2360032135.SGD","LU1066051811.HKD","LU0070302665.USD","LU2087621335.USD","LU0058720904.USD","LU0320765992.SGD","LU2491050071.SGD","BK4139","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197062628","title":"吉利德科学宣布终止Trodelvy联合Keytruda的III期Keynote-D46/Evoke-03研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1197062628","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197062628?lang=zh_cn&edition=full","pubTime":"2026-06-09 04:31","pubTimestamp":1780950708,"startTime":"0","endTime":"0","summary":"吉利德科学已决定终止其III期临床试验Keynote-D46/Evoke-03。该研究旨在评估其药物Trodelvy与默沙东的Keytruda联合用药方案。\n此项研究的终止意味着该联合疗法的开发进程已告一段落。吉利德科学未在本次公告中披露终止该研究的详细原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00B19Z3B42.SGD","LU2106854487.HKD","LU1430594728.SGD","LU2023250843.SGD","LU0985320562.USD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1989772840.SGD","IE0002141913.USD","LU0320765646.SGD","SG9999001440.SGD","SG9999015978.USD","BK4588","LU0889565916.HKD","LU0432979614.USD","LU2089984988.USD","LU1923622614.USD","LU1917777945.USD","LU1674673428.USD","LU0109394709.USD","LU0965508806.USD","IE00BZ1G4Q59.USD","LU1934455863.HKD","LU0859254822.USD","LU0122379950.USD","BK4007","LU0234572021.USD","LU0868494708.USD","LU0058720904.USD","LU1989771016.USD","LU2361044865.SGD","LU0130102774.USD","SG9999014575.USD","IE00BLSP4452.SGD","LU1974910355.USD","LU2125909593.SGD","LU1778281490.HKD","LU0965509283.SGD","LU1839511570.USD","LU1929549753.HKD","LU1989772923.USD","SG9999002224.SGD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU0265550359.USD","LU0266013472.USD","LU2491050071.SGD","IE00BN8TJ469.HKD","BK4532","SG9999014542.SGD","GILD","LU1066051225.USD","SGXZ57979304.SGD","BK4568","IE00BJT1NW94.SGD","LU2361045086.USD","LU1699723380.USD","LU1674673691.USD","LU1934455277.USD","LU2324357040.USD","SG9999014567.USD","LU0942090050.USD","LU0106261372.USD","SG9999001176.USD","LU2125909247.SGD","LU1066053197.SGD","LU2023250504.SGD","BK4559","LU0477156953.USD","LU2125154778.USD","LU1037948541.HKD","LU0648001328.SGD","LU2361044949.HKD","IE0009355771.USD","LU0234570918.USD","SG9999015952.SGD","IE00B7SZLL34.SGD","SG9999015358.SGD","IE00B4R5TH58.HKD","LU0861579265.USD","SG9999015986.USD","MRK","SG9999014559.SGD","BK4566","BK4550","LU1291159041.SGD","LU0130517989.USD","LU2491049909.HKD","IE00B19Z3581.USD","LU2357627491.SGD","IE00B3T34201.USD","SG9999002232.USD","LU1983299246.USD","SG9999013999.USD","LU1035773651.USD","LU1116320901.HKD","LU2491050154.USD","LU0980610538.SGD","LU0203347892.USD","BK4534","BK4533","LU0006306889.USD","LU0211331839.USD","BK4583","LU1093756325.SGD","LU1057294990.SGD","LU1934455194.USD","LU0823416689.USD","LU1066051811.HKD","LU0070302665.USD","LU2433249047.HKD","LU1023059063.AUD","LU2468319806.SGD","LU1093756168.USD","LU0098860793.USD","LU1571399168.USD","IE00BLSP4239.USD","LU1201861249.SGD","IE00BBT3K403.USD","LU1037948897.HKD","IE00B1BXHZ80.USD","LU1941712264.USD","IE000M9KFDE8.USD","LU0265550946.USD","LU1116320737.USD","LU2461242641.AUD","LU2087621335.USD","LU0203345920.USD","LU0238689110.USD","BK4516","LU1069347547.HKD","LU1162221912.USD","LU0289739699.SGD","LU0868494617.USD","LU0320765489.SGD","SG9999015945.SGD","IE00B2B36J28.USD","LU0965509101.SGD","BK4139","LU1941712348.USD","IE00BKVL7J92.USD","LU0114720955.EUR","LU1061106388.HKD","LU0320765992.SGD","LU1585245621.USD","SG9999001176.SGD","LU0965509010.AUD","IE0002270589.USD","LU2125154935.USD","SG9999015341.SGD","LU1066051498.USD","BK4585","LU2360032135.SGD","LU0208291251.USD","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641103919","title":"默沙东欣瑞来重磅上市,填补针对肺动脉高压根源治疗空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2641103919","media":"上观新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641103919?lang=zh_cn&edition=full","pubTime":"2026-06-08 12:10","pubTimestamp":1780891811,"startTime":"0","endTime":"0","summary":"默沙东今天宣布,全球首个针对肺动脉高压核心病理机制的全人源生物制剂欣瑞来(注射用索特西普)在中国境内上市,用于治疗世界卫生组织功能分级(WHOFC)Ⅱ-Ⅲ级的肺动脉高压(PAH,WHO第1组)成年患者,填补了针对PAH疾病根源的治疗空白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763195321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1116320737.USD","LU2491049909.HKD","IE00BBT3K403.USD","LU1035773651.USD","LU0432979614.USD","LU0265550946.USD","BK4550","LU0211331839.USD","LU1699723380.USD","LU0106261372.USD","LU0070302665.USD","LU1066051498.USD","LU2125154935.USD","LU1037948541.HKD","LU1571399168.USD","LU1941712264.USD","LU2360032135.SGD","LU0980610538.SGD","LU1585245621.USD","IE0009355771.USD","LU1929549753.HKD","SG9999015341.SGD","LU0203347892.USD","LU2491050154.USD","LU1069347547.HKD","LU1291159041.SGD","LU1057294990.SGD","LU0130102774.USD","LU2125909593.SGD","LU2433249047.HKD","LU1917777945.USD","BK4588","LU2468319806.SGD","LU2461242641.AUD","LU1934455277.USD","LU2125154778.USD","LU0265550359.USD","BK4559","LU0965509101.SGD","LU0985320562.USD","LU1201861249.SGD","LU2361044865.SGD","LU0320765646.SGD","LU1116320901.HKD","LU0006306889.USD","LU0238689110.USD","BK4585","LU0861579265.USD","LU0965509010.AUD","LU1983299246.USD","SG9999014559.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU0320765489.SGD","LU1989772923.USD","IE00BJJMRZ35.SGD","LU2106854487.HKD","LU1093756168.USD","BK4534","SG9999001176.SGD","LU0289739699.SGD","LU0234572021.USD","LU2361045086.USD","LU0965508806.USD","LU2361044949.HKD","SGXZ57979304.SGD","LU0266013472.USD","LU1989771016.USD","LU2357627491.SGD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","SG9999014575.USD","SG9999002232.USD","LU1093756325.SGD","LU1066051811.HKD","IE00BSNM7G36.USD","BK4533","IE00BLSP4452.SGD","MRK","LU0477156953.USD","LU1934455194.USD","LU1061106388.HKD","SG9999015358.SGD","LU1923622614.USD","IE00B4R5TH58.HKD","LU2023250843.SGD","LU0942090050.USD","LU1066053197.SGD","LU2125909247.SGD","LU0098860793.USD","BK4007","IE000M9KFDE8.USD","LU0122379950.USD","LU1037948897.HKD","LU1974910355.USD","LU0965509283.SGD","SG9999014567.USD","LU0868494708.USD","SG9999013999.USD","LU2089984988.USD","LU0058720904.USD","LU1941712348.USD","LU1934455863.HKD","LU2491050071.SGD","SG9999014542.SGD","IE00BN8TJ469.HKD","LU1162221912.USD","SG9999001176.USD","SG9999002224.SGD","LU0130517989.USD","LU1430594728.SGD","LU2324357040.USD","SG9999001440.SGD","LU0648001328.SGD","LU2112291526.USD","BK4516","LU2023250504.SGD","LU0859254822.USD","LU0208291251.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1066051225.USD","LU0203345920.USD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159254796","title":"异动解读|默沙东盘中上涨3.44%,制药板块整体反弹叠加HIV新药获中国优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1159254796","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159254796?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:14","pubTimestamp":1780582499,"startTime":"0","endTime":"0","summary":"6月4日,默沙东盘中上涨3.44%,报119.41美元/股,成交额2.04亿美元。消息面上,默沙东HIV-1新药多拉韦林伊拉曲韦片近日被中国CDE拟纳入优先审评,该药已于今年3月和4月分别在日本和美国获批上市,III期临床数据显示其非劣效于现有标准方案。此外,默沙东近期还与多家中国本土药企签署肿瘤领域合作协议,持续扩展在研管线布局。本次上涨或受板块情绪回暖及多重利好共振推动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170791258","title":"Apotex推出西格列汀片及西格列汀盐酸二甲双胍片,符合180天共享独占期资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1170791258","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170791258?lang=zh_cn&edition=full","pubTime":"2026-06-03 21:02","pubTimestamp":1780491743,"startTime":"0","endTime":"0","summary":"Apotex公司已正式推出西格列汀片以及西格列汀与盐酸二甲双胍的复方片剂。根据相关法规,这两款仿制药产品有资格获得180天的市场共享独占期。这一独占期安排意味着,在特定条件下,Apotex作为首仿药申请者,可在180天内与原创药企共同分享市场,而无须立即面对其他仿制药的完全竞争。此次仿制药的上市,预计将为糖尿病患者提供更多治疗选择,并可能通过市场竞争影响药品定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU1929549753.HKD","IE00BLSP4239.USD","LU2112291526.USD","SG9999014559.SGD","LU0070302665.USD","LU1941712264.USD","LU2491050071.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2461242641.AUD","LU2106854487.HKD","IE00BBT3K403.USD","LU0320765646.SGD","LU0859254822.USD","LU0868494617.USD","LU1934455863.HKD","LU0234572021.USD","IE00B2B36J28.USD","LU0965509010.AUD","LU0861579265.USD","LU0942090050.USD","LU2360032135.SGD","LU0965508806.USD","LU1291159041.SGD","LU0106261372.USD","LU2433249047.HKD","LU1989772923.USD","LU1162221912.USD","IE00B1BXHZ80.USD","LU1974910355.USD","LU0211331839.USD","LU1093756168.USD","IE00BLSP4452.SGD","LU1989771016.USD","LU1917777945.USD","LU2468319806.SGD","LU0868494708.USD","LU2125909593.SGD","LU2361044949.HKD","LU1116320737.USD","LU0058720904.USD","LU0238689110.USD","LU1093756325.SGD","LU0320765489.SGD","LU1066053197.SGD","SG9999015341.SGD","LU2357627491.SGD","LU2125154935.USD","IE00BN8TJ469.HKD","LU2023250504.SGD","LU0203345920.USD","LU2491049909.HKD","IE000M9KFDE8.USD","LU0965509283.SGD","LU0965509101.SGD","LU0980610538.SGD","BK4534","SG9999014567.USD","LU1430594728.SGD","LU0265550359.USD","LU2361044865.SGD","LU2491050154.USD","LU1066051225.USD","BK4007","LU0098860793.USD","BK4516","LU0648001328.SGD","LU1037948897.HKD","IE00BJT1NW94.SGD","SG9999015358.SGD","LU2023250843.SGD","LU0122379950.USD","LU1923622614.USD","LU0266013472.USD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1941712348.USD","LU0130517989.USD","LU0432979614.USD","LU2125154778.USD","SG9999002232.USD","LU2125909247.SGD","LU2361045086.USD","IE0002141913.USD","LU1037948541.HKD","LU0130102774.USD","LU1201861249.SGD","LU1983299246.USD","BK4588","MRK","LU2324357040.USD","LU1035773651.USD","SGXZ57979304.SGD","BK4559","LU0477156953.USD","LU1066051498.USD","LU0289739699.SGD","LU1585245621.USD","LU0203347892.USD","SG9999013999.USD","IE00B4R5TH58.HKD","LU0985320562.USD","LU1934455277.USD","LU0208291251.USD","LU1989772840.SGD","IE00BJJMRZ35.SGD","LU0265550946.USD","LU1061106388.HKD","LU2089984988.USD","SG9999001176.USD","SG9999002224.SGD","LU1934455194.USD","SG9999001176.SGD","SG9999014575.USD","BK4585","LU1066051811.HKD","LU1699723380.USD","LU1571399168.USD","LU1069347547.HKD","LU1057294990.SGD","SG9999014542.SGD","BK4533","SG9999001440.SGD","BK4550","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640705069","title":"百年德企重仓深圳,不止于制造","url":"https://stock-news.laohu8.com/highlight/detail?id=2640705069","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640705069?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:08","pubTimestamp":1780477680,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者陈思琦深圳报道近日,德国默克集团“默克大湾区创新与合作中心”在深圳南山区正式竣工。该中心定位为默克集团的创新研发载体,将通过整合全球创新资源,推动创新药物和生物技术的研发。21世纪经济报道记者梳理发现,今年以来,德国巨头与科研机构密集落子深圳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606033759081091.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606033759081091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1989771016.USD","SG9999002232.USD","LU0965508806.USD","LU1201861249.SGD","LU2433249047.HKD","LU0130517989.USD","IE00BBT3K403.USD","LU2491050071.SGD","LU1917777945.USD","IE00BN8TJ469.HKD","LU1941712348.USD","LU2468319806.SGD","BK4007","LU0238689110.USD","SG9999014559.SGD","LU1571399168.USD","LU1023059063.AUD","LU0070302665.USD","LU2125154935.USD","SG9999014542.SGD","SG9999014575.USD","BK4206","LU1934455863.HKD","LU1066051225.USD","LU1983299246.USD","LU2106854487.HKD","SG9999015358.SGD","SG9999014567.USD","SG9999001176.SGD","LU2361045086.USD","LU2125154778.USD","LU2361044949.HKD","LU0965509101.SGD","LU0859254822.USD","LU0289739699.SGD","BK4534","BK4543","BK4533","SG9999002224.SGD","LU1585245621.USD","LU1162221912.USD","IE00BLSP4452.SGD","LU2023250504.SGD","IE00BLSP4239.USD","LU1093756325.SGD","LU0234572021.USD","LU1934455194.USD","SG9999013999.USD","LU0098860793.USD","LU0006306889.USD","LU2112291526.USD","LU0265550946.USD","LU0965509283.SGD","IE00BJJMRZ35.SGD","LU0320765646.SGD","LU2023250843.SGD","BK4516","LU1066051498.USD","LU1116320901.HKD","LU0203345920.USD","LU1923622614.USD","BK4559","LU2324357040.USD","LU1934455277.USD","SGXZ57979304.SGD","LU2089984988.USD","LU1291159041.SGD","LU1066053197.SGD","IE000M9KFDE8.USD","LU0477156953.USD","LU0980610538.SGD","LU1989772923.USD","LU1430594728.SGD","LU0122379950.USD","LU0432979614.USD","LU1037948541.HKD","SG9999001176.USD","LU0320765489.SGD","MRK","LU0211331839.USD","IE00B2B36J28.USD","BK4585","LU0208291251.USD","LU2361044865.SGD","LU1989772840.SGD","LU1941712264.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU0868494708.USD","LU2125909593.SGD","LU1093756168.USD","IE0002141913.USD","LU0130102774.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1699723380.USD","LU1037948897.HKD","LU0106261372.USD","SG9999015341.SGD","SIEGY","LU0266013472.USD","LU0868494617.USD","LU0942090050.USD","LU0648001328.SGD","LU2357627491.SGD","LU2491049909.HKD","LU0058720904.USD","LU1035773651.USD","LU1066051811.HKD","BK4588","IE00B4R5TH58.HKD","BK4550","LU0965509010.AUD","LU1116320737.USD","IE00B1BXHZ80.USD","LU0861579265.USD","LU1929549753.HKD","LU1061106388.HKD","LU2360032135.SGD","LU0203347892.USD","LU0265550359.USD","LU2461242641.AUD","LU0985320562.USD","LU2491050154.USD","LU1974910355.USD","LU2125909247.SGD","SG9999001440.SGD","LU1057294990.SGD","LU1069347547.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155510638","title":"异动解读|默沙东盘中下跌3.01%,报115.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155510638","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155510638?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:47","pubTimestamp":1780325232,"startTime":"0","endTime":"0","summary":"6月1日,默沙东盘中下跌3.01%,报115.17美元/股,成交额2.15亿美元。默沙东所在的制药行业整体承压,个股中,礼来跌2.44%,强生跌1.56%,辉瑞跌2.39%,施贵宝跌3.53%,诺和诺德跌3.14%。默克制药公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品,公司营运包括制药及动物保健国际两个经营分部。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172241710","title":"Adcendo Aps:双方公司保留各自化合物全部商业权利,涵盖单药及联合疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1172241710","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172241710?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:09","pubTimestamp":1779793787,"startTime":"0","endTime":"0","summary":"Adcendo Aps宣布,合作双方将各自保留其相关化合物的全部商业化权益,这些权益范围包括作为单一疗法使用,或与其他疗法进行联合应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1934455277.USD","LU2357627491.SGD","LU0980610538.SGD","IE00B2B36J28.USD","SG9999001176.USD","LU2491050154.USD","LU1162221912.USD","LU2125909247.SGD","LU2023250504.SGD","SG9999014542.SGD","LU0320765646.SGD","LU0965508806.USD","LU2125909593.SGD","LU0648001328.SGD","BK4550","BK4588","BK4007","LU1037948897.HKD","LU2112291526.USD","LU0265550946.USD","LU1989772840.SGD","SG9999015358.SGD","LU0868494617.USD","LU1035773651.USD","SG9999002224.SGD","LU2106854487.HKD","LU0070302665.USD","LU0477156953.USD","LU0320765489.SGD","LU2361044949.HKD","SG9999013999.USD","LU0265550359.USD","LU2433249047.HKD","LU1585245621.USD","LU0432979614.USD","LU1116320737.USD","LU1989772923.USD","SGXZ57979304.SGD","LU2491049909.HKD","LU0985320562.USD","LU1201861249.SGD","LU1974910355.USD","SG9999001440.SGD","LU1430594728.SGD","LU1989771016.USD","LU1066053197.SGD","LU0122379950.USD","LU2324357040.USD","LU2125154935.USD","SG9999015341.SGD","LU1066051811.HKD","LU1934455194.USD","LU1093756168.USD","BK4534","BK4585","LU2089984988.USD","LU2491050071.SGD","LU1571399168.USD","LU0238689110.USD","LU2361044865.SGD","BK4533","LU0208291251.USD","LU0289739699.SGD","LU1057294990.SGD","LU1923622614.USD","IE00B1BXHZ80.USD","LU2361045086.USD","LU2125154778.USD","LU1983299246.USD","LU0098860793.USD","LU2360032135.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0965509010.AUD","LU1917777945.USD","LU1699723380.USD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0942090050.USD","LU0211331839.USD","LU1929549753.HKD","LU1116320901.HKD","LU1023059063.AUD","MRK","IE00BBT3K403.USD","LU1037948541.HKD","IE00BJT1NW94.SGD","LU0130517989.USD","LU0203345920.USD","BK4559","LU0106261372.USD","LU1066051225.USD","LU2023250843.SGD","IE0009355771.USD","IE00BSNM7G36.USD","SG9999014575.USD","LU1941712348.USD","LU0266013472.USD","LU0058720904.USD","IE00BLSP4239.USD","LU1934455863.HKD","LU0965509283.SGD","LU1093756325.SGD","IE000M9KFDE8.USD","SG9999014559.SGD","LU0859254822.USD","LU1069347547.HKD","LU1941712264.USD","LU0006306889.USD","LU0130102774.USD","LU0965509101.SGD","SG9999014567.USD","IE00BN8TJ469.HKD","LU2461242641.AUD","LU2468319806.SGD","LU0868494708.USD","LU1066051498.USD","LU1291159041.SGD","LU0861579265.USD","IE00B4R5TH58.HKD","LU0203347892.USD","BK4516","IE00BFTCPJ56.SGD","LU0234572021.USD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142473894","title":"Adcendo Aps与默沙东达成临床合作与供应协议,共同评估Adce-T02与Keytruda联合疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1142473894","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142473894?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:08","pubTimestamp":1779793708,"startTime":"0","endTime":"0","summary":"Adcendo Aps宣布与默沙东(Merck)达成一项临床合作与供应协议。双方将携手评估其候选药物Adce-T02与默沙东的抗PD-1疗法Keytruda(帕博利珠单抗)联合使用的潜力。\n此项合作旨在探索联合用药方案在特定适应症中的疗效与安全性。通过结合Adcendo的靶向疗法与默沙东已确立的免疫肿瘤药物,双方期望能开发出更具创新性的癌症治疗策略。协议的达成标志着Adcendo在推进其研发管线的战略布局上迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0868494708.USD","SG9999014575.USD","LU0432979614.USD","SG9999014559.SGD","SG9999015358.SGD","LU1066051811.HKD","MRK","LU1934455194.USD","LU2468319806.SGD","LU0942090050.USD","LU1162221912.USD","LU1430594728.SGD","LU0208291251.USD","LU2023250504.SGD","LU0965508806.USD","LU0477156953.USD","LU0320765489.SGD","LU1917777945.USD","IE00BN8TJ469.HKD","LU0965509101.SGD","LU2324357040.USD","LU1929549753.HKD","LU0203347892.USD","LU1066051498.USD","LU1974910355.USD","LU1983299246.USD","LU2023250843.SGD","IE0002141913.USD","LU0106261372.USD","SGXZ57979304.SGD","LU2491050071.SGD","LU0211331839.USD","IE00BJT1NW94.SGD","LU1941712264.USD","LU0265550946.USD","IE00BFTCPJ56.SGD","IE000M9KFDE8.USD","LU0980610538.SGD","BK4534","LU2491049909.HKD","LU1069347547.HKD","IE0009355771.USD","LU0265550359.USD","LU1201861249.SGD","LU0058720904.USD","LU1923622614.USD","LU1093756325.SGD","LU1989772840.SGD","LU2491050154.USD","LU2125909593.SGD","BK4559","LU1699723380.USD","BK4550","LU1066051225.USD","LU2360032135.SGD","LU2112291526.USD","SG9999014567.USD","LU1066053197.SGD","SG9999001176.SGD","SG9999002224.SGD","LU1037948897.HKD","LU2125154778.USD","LU1571399168.USD","LU2361044865.SGD","BK4007","BK4588","LU0238689110.USD","LU2433249047.HKD","IE00B1BXHZ80.USD","LU0648001328.SGD","LU2357627491.SGD","LU0320765646.SGD","IE00BBT3K403.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0098860793.USD","SG9999001440.SGD","SG9999014542.SGD","LU0985320562.USD","IE00BSNM7G36.USD","LU0861579265.USD","LU1585245621.USD","LU0859254822.USD","LU2461242641.AUD","LU1116320901.HKD","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU1037948541.HKD","BK4585","LU2089984988.USD","LU2361044949.HKD","LU1989772923.USD","BK4516","LU2106854487.HKD","LU1116320737.USD","SG9999015341.SGD","LU2125154935.USD","SG9999013999.USD","LU1934455863.HKD","LU0266013472.USD","LU0006306889.USD","LU1941712348.USD","LU0070302665.USD","LU2125909247.SGD","LU0203345920.USD","LU0234572021.USD","LU0868494617.USD","LU2361045086.USD","SG9999002232.USD","SG9999001176.USD","LU1061106388.HKD","IE00BLSP4239.USD","LU1023059063.AUD","LU1093756168.USD","IE00BLSP4452.SGD","LU1934455277.USD","LU0130102774.USD","LU0130517989.USD","LU1291159041.SGD","LU0965509283.SGD","LU0965509010.AUD","LU1035773651.USD","LU1989771016.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193611796","title":"Adcendo Aps达成协议:公司将资助1B期临床试验,默沙东将提供帕博利珠单抗","url":"https://stock-news.laohu8.com/highlight/detail?id=1193611796","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193611796?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:08","pubTimestamp":1779793701,"startTime":"0","endTime":"0","summary":"根据一项新达成的协议,Adcendo Aps公司将负责资助一项1B期临床试验,而默沙东将为此项试验提供其药物帕博利珠单抗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","IE00BLSP4452.SGD","LU2361044949.HKD","LU0106261372.USD","LU0122379950.USD","LU0265550359.USD","LU2324357040.USD","LU0868494708.USD","LU1037948541.HKD","LU2491049909.HKD","LU0965508806.USD","LU0130102774.USD","LU0208291251.USD","LU1941712348.USD","LU0320765489.SGD","SG9999001440.SGD","LU1066051225.USD","SG9999014575.USD","IE00BSNM7G36.USD","LU2357627491.SGD","SG9999014559.SGD","LU1934455277.USD","LU1066051498.USD","BK4588","LU2023250843.SGD","LU1069347547.HKD","LU0477156953.USD","SG9999014542.SGD","LU1066053197.SGD","LU1989772840.SGD","LU1571399168.USD","LU2361044865.SGD","LU0234572021.USD","BK4533","IE00B2B36J28.USD","SG9999015341.SGD","LU0965509010.AUD","IE00BLSP4239.USD","LU0985320562.USD","LU2361045086.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU1430594728.SGD","LU2360032135.SGD","LU2089984988.USD","LU1116320737.USD","LU2125154935.USD","BK4559","LU2433249047.HKD","LU1974910355.USD","LU1923622614.USD","LU2461242641.AUD","LU2125909593.SGD","LU1983299246.USD","LU1093756325.SGD","LU0203345920.USD","BK4585","LU1057294990.SGD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0859254822.USD","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD","IE00B1BXHZ80.USD","MRK","LU2468319806.SGD","LU0006306889.USD","LU1989771016.USD","LU1917777945.USD","BK4516","BK4534","IE00BBT3K403.USD","SG9999015358.SGD","LU0070302665.USD","IE0002141913.USD","LU1035773651.USD","SG9999014567.USD","IE0009355771.USD","SG9999002232.USD","LU0058720904.USD","LU2125154778.USD","LU0965509101.SGD","LU0289739699.SGD","LU0432979614.USD","LU0965509283.SGD","LU0266013472.USD","LU0098860793.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0980610538.SGD","LU0203347892.USD","SG9999002224.SGD","LU0238689110.USD","LU2106854487.HKD","LU1934455194.USD","LU2125909247.SGD","LU1989772923.USD","LU0868494617.USD","SG9999013999.USD","BK4550","LU1066051811.HKD","LU0265550946.USD","LU1201861249.SGD","LU1941712264.USD","LU2023250504.SGD","LU2491050154.USD","LU2112291526.USD","LU1699723380.USD","LU1116320901.HKD","SG9999001176.SGD","LU0942090050.USD","LU1093756168.USD","LU1585245621.USD","BK4007","LU1061106388.HKD","LU0130517989.USD","LU0648001328.SGD","LU1037948897.HKD","LU1929549753.HKD","LU1934455863.HKD","LU0211331839.USD","LU0861579265.USD","LU2491050071.SGD","LU1291159041.SGD","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637343626","title":"默沙东K药联合Padcev获欧盟CHMP积极意见,用于治疗顺铂不耐受肌层浸润性膀胱癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2637343626","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637343626?lang=zh_cn&edition=full","pubTime":"2026-05-22 23:28","pubTimestamp":1779463680,"startTime":"0","endTime":"0","summary":"默沙东于5月22日宣布,欧洲药品管理局人用药品委员会已采纳积极意见,推荐批准KEYTRUDA联合Padcev用于治疗顺铂不耐受的可切除肌层浸润性膀胱癌成人患者,作为新辅助治疗并在根治性膀胱切除术后继续作为辅助治疗。该试验在顺铂不耐受或拒绝接受含顺铂化疗的MIBC患者中,比较了围手术期K药联合Padcev治疗与单纯手术的效果。欧洲委员会预计将在2026年第三季度前做出最终审批决定。目前该联合疗法已在美国获得批准用于相同适应症。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-22/doc-inhyuwef7534467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0265550359.USD","LU1983299246.USD","SG9999014567.USD","LU2106854487.HKD","SG9999013999.USD","IE00B2B36J28.USD","LU2491050154.USD","IE00BBT3K403.USD","LU1934455194.USD","LU2089984988.USD","SGXZ57979304.SGD","LU1069347547.HKD","LU1934455277.USD","LU1917777945.USD","LU0965509010.AUD","LU1201861249.SGD","LU0980610538.SGD","LU0122379950.USD","LU0234572021.USD","LU0477156953.USD","SG9999002232.USD","BK4533","LU1571399168.USD","LU1162221912.USD","IE00BJT1NW94.SGD","LU2125154778.USD","LU1585245621.USD","LU1061106388.HKD","LU0203345920.USD","BK4534","LU1929549753.HKD","IE00BJJMRZ35.SGD","LU1974910355.USD","LU0098860793.USD","LU1066053197.SGD","LU1989772840.SGD","LU0985320562.USD","LU2361044865.SGD","SG9999014542.SGD","LU1934455863.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU0058720904.USD","LU2361044949.HKD","LU0965509283.SGD","LU1037948897.HKD","LU0965509101.SGD","LU0203347892.USD","LU0266013472.USD","LU0106261372.USD","LU2360032135.SGD","SG9999001440.SGD","BK4007","LU1699723380.USD","LU2468319806.SGD","LU1116320737.USD","LU0130102774.USD","LU0859254822.USD","BK4550","MRK","SG9999015358.SGD","IE00BN8TJ469.HKD","LU2361045086.USD","LU0070302665.USD","LU1430594728.SGD","LU0265550946.USD","LU2433249047.HKD","LU0320765489.SGD","LU2461242641.AUD","LU2491049909.HKD","SG9999002224.SGD","LU0861579265.USD","LU0289739699.SGD","LU2491050071.SGD","LU0432979614.USD","LU0208291251.USD","LU1066051498.USD","LU1093756325.SGD","LU1989771016.USD","LU0868494708.USD","LU2125154935.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","SG9999014559.SGD","LU0320765646.SGD","LU1093756168.USD","BK4585","LU2125909593.SGD","LU1941712348.USD","LU1037948541.HKD","LU1057294990.SGD","LU2125909247.SGD","SG9999015341.SGD","LU1116320901.HKD","LU1291159041.SGD","LU2023250504.SGD","BK4516","SG9999001176.SGD","IE0002141913.USD","BK4559","LU1989772923.USD","LU0648001328.SGD","LU0211331839.USD","IE00B4R5TH58.HKD","IE0009355771.USD","SG9999014575.USD","LU2112291526.USD","LU0006306889.USD","LU1941712264.USD","LU2357627491.SGD","LU0238689110.USD","LU2023250843.SGD","LU0965508806.USD","LU1923622614.USD","LU2324357040.USD","LU0130517989.USD","LU1066051225.USD","IE000M9KFDE8.USD","IE00BSNM7G36.USD","LU1035773651.USD","LU1066051811.HKD","IE00B1BXHZ80.USD","SG9999001176.USD","LU0942090050.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125632815","title":"默沙东股价因癌症数据上涨,为何这家制药商不会仅依赖一款“王牌药物”?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125632815","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125632815?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:57","pubTimestamp":1779461871,"startTime":"0","endTime":"0","summary":"默沙东正试图缓解2028年即将到来的冲击,届时Keytruda的核心专利保护将开始到期。作为肿瘤治疗领域公认的“神药”,Keytruda是有史以来销量最高的药物之一,因此其失去市场独占权将对公司构成重大不利影响。2022年,默沙东与这家中国药企达成独家授权协议,共同建立用于癌症治疗的ADC产品组合。周五股价上涨还受到监管层面积极进展的进一步推动。","market":"us","thumbnail":"https://community-static.tradeup.com/news/46fe1aebdcc6399ee66a93a44835bba6","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/46fe1aebdcc6399ee66a93a44835bba6"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1524d98f25a887386dd8f38c500227b6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"默沙东股价因癌症数据上涨,为何这家制药商不会仅依赖一款“王牌药物”?","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637531064","title":"默沙东(MRK)与科伦联合研发取得突破 肺癌新药临床效果亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2637531064","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637531064?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:14","pubTimestamp":1779459290,"startTime":"0","endTime":"0","summary":"金吾财讯 | 科伦生物周四披露重要临床进展,企业与默沙东合作研发的抗体药物偶联物,相关疗法在晚期肺癌临床试验中,疗效表现超越常规抗 PD-1 治疗方案。公开试验摘要显示,默沙东 2022 年取得大中华区以外权益的 sac-TMT,可显著降低 65% 疾病进展与死亡风险,数据具备统计学价值。安全性层面两组差异明显,联合用药重度不良反应发生率为 55%,单药组仅 31%。两类药物停药相关不良反应占比分别为 4% 与 5%,单药停药比例同样为 5%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1524d98f25a887386dd8f38c500227b6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300749","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU1929549753.HKD","IE00BLSP4239.USD","LU2112291526.USD","SG9999014559.SGD","LU0070302665.USD","LU1941712264.USD","LU2491050071.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2461242641.AUD","LU1064131003.USD","LU2106854487.HKD","IE00BBT3K403.USD","LU0320765646.SGD","LU0859254822.USD","LU0868494617.USD","LU1934455863.HKD","LU0234572021.USD","IE00B2B36J28.USD","LU0965509010.AUD","LU1979443071.USD","LU0861579265.USD","LU0942090050.USD","LU2360032135.SGD","LU0965508806.USD","LU1291159041.SGD","LU0106261372.USD","LU2433249047.HKD","LU1989772923.USD","LU1162221912.USD","IE00B1BXHZ80.USD","LU1974910355.USD","LU0211331839.USD","LU1093756168.USD","IE00BLSP4452.SGD","LU1989771016.USD","LU1917777945.USD","LU2468319806.SGD","002422","LU0868494708.USD","LU2125909593.SGD","LU2361044949.HKD","LU1116320737.USD","LU0058720904.USD","LU0238689110.USD","LU1093756325.SGD","LU0320765489.SGD","LU1066053197.SGD","SG9999015341.SGD","LU2357627491.SGD","LU2125154935.USD","IE00BN8TJ469.HKD","LU2023250504.SGD","LU0203345920.USD","LU2491049909.HKD","IE000M9KFDE8.USD","LU0965509283.SGD","LU0965509101.SGD","LU0980610538.SGD","BK4534","SG9999014567.USD","LU1430594728.SGD","LU0265550359.USD","LU2361044865.SGD","LU2491050154.USD","LU1066051225.USD","BK4007","LU0098860793.USD","BK4516","LU1064130708.USD","LU0648001328.SGD","LU2148510915.USD","LU1037948897.HKD","IE00BJT1NW94.SGD","SG9999015358.SGD","LU2023250843.SGD","LU0122379950.USD","LU1923622614.USD","LU0266013472.USD","IE00BSNM7G36.USD","BK0060","LU1023059063.AUD","LU1941712348.USD","LU0130517989.USD","LU0432979614.USD","LU2125154778.USD","SG9999002232.USD","LU2125909247.SGD","LU2361045086.USD","IE0002141913.USD","LU1037948541.HKD","LU0130102774.USD","LU1201861249.SGD","LU1983299246.USD","BK4588","MRK","LU2324357040.USD","LU1035773651.USD","SGXZ57979304.SGD","BK4559","LU0477156953.USD","LU1066051498.USD","LU0289739699.SGD","LU0203347892.USD","LU1585245621.USD","SG9999013999.USD","IE00B4R5TH58.HKD","LU0985320562.USD","LU1934455277.USD","BK0239","LU0208291251.USD","LU1934453819.USD","LU1989772840.SGD","IE00BJJMRZ35.SGD","LU0265550946.USD","LU1061106388.HKD","LU2089984988.USD","SG9999001176.USD","SG9999002224.SGD","LU1934455194.USD","SG9999001176.SGD","SG9999014575.USD","BK4585","LU1066051811.HKD","LU1699723380.USD","LU1571399168.USD","LU1069347547.HKD","LU1057294990.SGD","SG9999014542.SGD","BK4533","SG9999001440.SGD","BK4550","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":-0.0387},{"period":"1month","weight":0.0316},{"period":"3month","weight":-0.0084},{"period":"6month","weight":0.1585},{"period":"1year","weight":0.4062},{"period":"ytd","weight":0.0916}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.1253},{"period":"6month","weight":0.1243},{"period":"1year","weight":0.2644},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.565217,"avgChangeRate":0.010352},{"month":2,"riseRate":0.456522,"avgChangeRate":0.000847},{"month":3,"riseRate":0.608696,"avgChangeRate":-0.003426},{"month":4,"riseRate":0.595745,"avgChangeRate":0.014758},{"month":5,"riseRate":0.638298,"avgChangeRate":0.017693},{"month":6,"riseRate":0.510638,"avgChangeRate":0.012069},{"month":7,"riseRate":0.478261,"avgChangeRate":0.003083},{"month":8,"riseRate":0.5,"avgChangeRate":0.00331},{"month":9,"riseRate":0.521739,"avgChangeRate":-0.006239},{"month":10,"riseRate":0.543478,"avgChangeRate":0.018718},{"month":11,"riseRate":0.717391,"avgChangeRate":0.032717},{"month":12,"riseRate":0.608696,"avgChangeRate":0.013778}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}